Cordatus Wealth Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,031 shares of the healthcare conglomerate’s stock after buying an additional 46 shares during the quarter. UnitedHealth Group accounts for 2.1% of Cordatus Wealth Management LLC’s portfolio, making the stock its 10th largest position. Cordatus Wealth Management LLC’s holdings in UnitedHealth Group were worth $5,865,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC increased its position in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Swedbank AB bought a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in UnitedHealth Group by 107.8% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after buying an additional 1,196,758 shares during the period. Lone Pine Capital LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth $480,903,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Up 0.5 %
Shares of UNH stock traded up $2.99 on Thursday, hitting $565.95. The stock had a trading volume of 459,511 shares, compared to its average volume of 3,896,059. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a 50 day moving average price of $582.60 and a 200 day moving average price of $540.48. The company has a market cap of $522.61 billion, a PE ratio of 36.72, a P/E/G ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.48%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on the stock. Truist Financial reiterated a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. KeyCorp started coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Finally, Cantor Fitzgerald lifted their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $615.53.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- How to Invest in Insurance Companies: A Guide
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Stock Market Sectors: What Are They and How Many Are There?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Investing in Travel Stocks Benefits
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.